In this study, TRAIL acted not only as a targeting ligand for death receptor 5, which is abundant in cancer cells, but also induced apoptosis in cancer cells, thus amplifying the therapeutic effect of triptolide loaded into exosomes [56]. Here, TNFRSF10B is linked to cancer.